ILLUMINA, INC.
For the period ended Dec 28, 2025. Filed Feb 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 12, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
6. Stockholders’ Equity
The 2015 Stock and Incentive Compensation Plan (the 2015 Stock Plan) and the New Hire Stock and Incentive Plan allow for the issuance of stock options, performance stock options, restricted stock units and awards and performance stock units. In Q2 2025, the Company’s stockholders approved an amendment and restatement of the Amended and Restated 2015 Stock Plan to, among other things, increase the maximum number of shares authorized for issuance by 7.9 million shares. In 2024, in connection with the GRAIL Spin-Off, all unvested RSU and PSU were equitably adjusted pursuant to the plan to preserve their intrinsic value and the number of shares reserved for issuance under the 2015 Stock Plan was increased by 160,000 shares. As of December 28, 2025, approximately 11.5 million shares remained available for future grants under the Second Amended and Restated 2015 Stock Plan. There is no set number of shares reserved for issuance under the New Hire Stock and Incentive Plan.
Restricted Stock
We issue restricted stock units (RSU) and performance stock units (PSU), both of which are considered restricted stock. We grant restricted stock pursuant to the Second Amended and Restated 2015 Stock Plan and satisfy such grants through the issuance of either new shares or shares from treasury stock. RSU are share awards that, upon vesting, will deliver to the holder shares of our common stock. RSU generally vest over afour-year period with equal vesting annually. We issue PSU for which the number of shares issuable at the end of athree-year performance period is based on our performance relative to specified operating margin targets (OM PSU) and PSU with a market condition that vest based on the Company’s relative total shareholder return as compared to a peer group of companies measured over athree-fiscal year performance period (rTSR PSU). Depending on the actual performance over the measurement period, an rTSR PSU award recipient could receive up to 175% of the granted award. Beginning in 2025, we no longer issue PSU for which the number of shares issuable at the end of a three-year performance period is based on our performance relative to specified earnings per share targets (EPS PSU). Shares issuable under all RSU and PSU awards are subject to continued employment through the vesting period.
Restricted stock activity was as follows:
| Restricted Stock Units (RSU) · Performance Stock Units(PSU) (1) · Weighted-Average Grant-Date Fair Value per Share | ||||
|---|---|---|---|---|
| Units in thousands · RSU · PSU | ||||
| Outstanding at January 1, 2023 | 1,611 | 74 | $311.23 | $446.74 |
| Awarded | 2,032 | 39 | $195.94 | $239.98 |
| Vested | (987) | — | $268.08 | $— |
| Cancelled | (458) | (113) | $253.52 | $299.98 |
| Outstanding at December 31, 2023 | 2,198 | — | $236.32 | $— |
| Awarded | 2,788 | 729 | $133.73 | $164.38 |
| Unvested adjustment for GRAIL Spin-Off | 107 | 12 | $— | $— |
| Vested | (771) | — | $249.70 | $— |
| Cancelled | (443) | (41) | $195.11 | $167.68 |
| Outstanding at December 29, 2024 | 3,879 | 700 | $158.60 | $164.87 |
| Awarded | 1,812 | 407 | $86.70 | $85.67 |
| Vested | (1,307) | (55) | $180.78 | $247.32 |
| Cancelled | (646) | (196) | $142.26 | $156.52 |
| Outstanding at December 28, 2025 | 3,738 | 856 | $118.82 | $123.77 |
(1)For OM and EPS PSU, the number of units reflect the estimated number of shares to be issued at the end of the performance period. For rTSR PSU, the number of units reflect the estimated number of shares to be issued based on performance as of the current reporting period. Awarded units are presented net of performance adjustments.
Pre-tax intrinsic value and fair value of vested restricted stock was as follows:
| In millions | 2025 | 2024 | 2023 |
|---|---|---|---|
| Pre-tax intrinsic value of outstanding restricted stock: | |||
| RSU | $504 | $525 | $306 |
| PSU | $116 | $95 | $— |
| Fair value of restricted stock vested: | |||
| RSU | $146 | $116 | $122 |
| PSU | $7 | $— | $— |
Stock Options
Stock option activity was as follows:
| Units in thousands | Options | Weighted-AverageExercise Price | Performance Stock Options (1) | Weighted-AverageExercise Price |
|---|---|---|---|---|
| Outstanding at January 1, 2023 | 187 | $319.72 | 17 | $85.54 |
| Exercised | (8) | $71.09 | (1) | $16.69 |
| Cancelled | (144) | $330.25 | — | $— |
| Outstanding at December 31, 2023 | 35 | $330.25 | 16 | $87.74 |
| Cancelled | (35) | $330.25 | (16) | $87.74 |
| Outstanding at December 29, 2024 and December 28, 2025 | — | $— | — | $— |
(1)In connection with the GRAIL acquisition, we issued replacement performance stock options to GRAIL employees in 2021. The number of units reflected awards that had been granted and for which it was assumed to be probable that the underlying performance goals would be achieved. In connection with the GRAIL Spin-Off, all outstanding performance stock options were assumed by GRAIL in 2024.
Liability-Classified Awards
Prior to the GRAIL Spin-Off in 2024, we granted cash-based equity incentive awards to GRAIL employees, which were accounted for as liability-classified awards. In connection with the Spin-Off, these awards were assumed by GRAIL. For purposes of valuation and performance measurement of the awards, GRAIL’s stand-alone value calculation, as estimated by GRAIL based on its analysis and on input from independent valuation advisors and analyses, was used. The awards generally had terms offour years and vested infour equal installments on each anniversary of the grant date, subject to continued employment through the vesting period.
Cash-based equity incentive award activity was as follows:
| In millions | |
|---|---|
| Outstanding at January 1, 2023 | $293 |
| Granted | 116 |
| Vested and paid in cash | (77) |
| Cancelled | (32) |
| Change in fair value | (8) |
| Outstanding at December 31, 2023 | 292 |
| Granted | 67 |
| Vested and paid in cash | (54) |
| Cancelled | (13) |
| Change in fair value | (9) |
| Derecognition for GRAIL Spin-Off (1) | (283) |
| Outstanding at December 29, 2024 and December 28, 2025 | $— |
(1)The estimated liability immediately prior to the Spin-Off, recorded in accrued liabilities, was $53 million, which was disposed of as part of GRAIL’s net assets. See note 8. GRAIL Spin-Off for additional details.
We recognized share-based compensation expense for these cash-based equity incentive awards of $52 million in 2024, prior to the Spin-Off of GRAIL, and of $95 million in 2023.
Employee Stock Purchase Plan
The 2000 Employee Stock Purchase Plan, or ESPP, permits eligible employees to purchase common stock at a discount through payroll deductions during defined offering periods. The price at which stock is purchased under the ESPP is equal to 85% of the fair market value of the common stock on the first day of the offering period or purchase date, whichever is lower. The initial offering period commenced in July 2000. During 2025, 2024, and 2023, approximately 0.6 million,0.5 million, and 0.4 million shares, respectively, were issued under the ESPP. As of December 28, 2025, approximately 11.8 million shares remained available for issuance under the ESPP.
The assumptions used for the specified reporting periods and the resulting estimates of weighted-average fair value per share for stock purchased under the ESPP were as follows:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Risk-free interest rate | 3.82% - 4.94% | 4.35% - 5.54% | 0.78% - 5.54% |
| Expected volatility | 41% - 48% | 41% - 49% | 41% - 51% |
| Expected term | 0.5 - 1.0 year | 0.5 - 1.1 year | 0.5 - 1.1 year |
| Expected dividends | 0% | 0% | 0% |
| Weighted-average grant-date fair value per share | $25.94 | $37.24 | $49.87 |
Share-Based Compensation
Share-based compensation expense, which includes expense for both equity and liability-classified awards, reported in our consolidated statements of operations was as follows:
| In millions | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cost of product revenue | $20 | $25 | $29 |
| Cost of service and other revenue | 3 | 6 | 7 |
| Research and development | 107 | 146 | 155 |
| Selling, general and administrative | 145 | 194 | 189 |
| Share-based compensation expense, before taxes | 275 | 371 | 380 |
| Related income tax benefits | (61) | (83) | (87) |
| Share-based compensation expense, net of taxes | $214 | $288 | $293 |
As of December 28, 2025, unrecognized compensation cost, related to restricted stock and ESPP shares issued to date, of $391 million was expected to be recognized over a weighted-average period of approximately 2.3 years.
Share Repurchases
In August 2024, our Board of Directors authorized a share repurchase program, which canceled and superseded all prior and available repurchase authorizations, to repurchase up to $1.5 billion of our outstanding common stock. The repurchases may be completed through open market purchases, pursuant to Rule 10b5-1 or Rule 10b-18, or through an accelerated share repurchase program. Authorizations to repurchase up to $643 million of our outstanding common stock remained available as of December 28, 2025. We didnot repurchase any shares during 2023.
Share repurchase activity was as follows:
| In millions, except shares in thousands | 2025 | 2024 |
|---|---|---|
| Number of shares repurchased | 7,790 | 904 |
| Total cost of shares repurchased (1) | $748 | $116 |
(1)Total cost of shares repurchased includes the 1% excise tax imposed as part of the Inflation Reduction Act of 2022, which is calculated based on share repurchases, net of certain share issuances, and was immaterial for all periods presented.
Subsequent to December 28, 2025 and through February 11, 2026, we repurchased an additional approximate 264,000 shares of our common stock for approximately $32 million.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.